Knokke-Heist (Belgium), 30 October 2026, 6:00 a.m.; bonyf NV (Ticker: MLBON), a leader in dental consumer goods, professional dental consumables and dermatological solutions, shares its CEO’s message to shareholders, highlighting the encouraging response to Periocream in Italy and the company’s strategy for sustainable growth and long-term shareholder value.

Dear Shareholders,

As Founder and CEO of bonyf, I fully understand the disappointment caused by our current share price, which remains far below the levels reached in the past. I particularly regret the financial impact on shareholders who may need to sell their shares at today’s low valuation. Nevertheless, I remain confident in the commercial potential of bonyf and the opportunities ahead.

We are actively promoting our brands through targeted social media advertising, and we are beginning to see encouraging results. However, our main focus remains Periocream, which we believe represents a significant growth opportunity for bonyf.

As announced in our previous press release, we are currently negotiating distribution agreements in more than 15 countries, with Italy leading the way. In Italy, our specialized dental platform partner has achieved an exceptionally encouraging response to its Periocream sample campaign.

More than 1,300 dentists and dental hygienists have requested and received a Periocream sample. According to our Italian partner, this is a remarkable result and demonstrates strong professional interest in the product. The next crucial step is to convert this interest into regular use of Periocream by dental professionals, generating repeat orders and sustainable sales. We believe that successful adoption in Italy could become a model for expansion into other countries.

I firmly believe that as Periocream gains regular professional users and generates recurring sales, the resulting business growth has the potential to be reflected in bonyf’s share price over time. Our focus is on delivering commercial results that create lasting value for our shareholders.

Thank you for your continued patience, trust and support.

Jean-Pierre Bogaert – Founder & CEO – bonyf NV

Forward-Looking Statements

This press release contains forward-looking statements regarding bonyf’s commercial development, distribution opportunities and future growth. Actual results may differ from expectations. Sample requests do not guarantee future sales, and no assurance can be given regarding future financial performance or share-price developments

 

bonyf’s strengths

• Products with patented formulations
• Produced in Switzerland compliant with stringent international quality regulations
• Proven clinical efficacy
• Commercial presence in 37 countries
• Prospects for solid growth and rapid profitability
• A fast-growing oral and dental care market